Syntax Research »

Regeneron Pharmaceuticals shares owned by Syntax Research

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Syntax Research from 13F filings

Historical chart of Syntax Research investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Syntax Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Syntax Research

Quarter filed Position value Share count Share price at filing
2024-03-31 $332k 345 962.49
2023-12-31 $303k 345 878.29

More positions owned by Syntax Research

Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Usa Value (VLUE)
Ishares Tr Core S&p Mcp Etf (IJH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Proshares Tr S&p 500 Dv Arist (NOBL)
Ishares Tr Msci Acwi Ex Us (ACWX)
Ishares Tr Core Msci Euro (IEUR)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Qualcomm (QCOM)
Air Products & Chemicals (APD)
Nutrien (NTR)
Newmont Mining Corporation (NEM)
American Tower Reit (AMT)

View all positions for Syntax Research

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals